Navigation Links
Survey of More than 600 Patients Treated with Tracleer(R) (bosentan) Reveals Actelion Sure Steps(R) Patient Support Program Provides Valuable Educational Information
Date:12/18/2007

wo significant safety concerns: potential for serious liver injury (including rare cases of liver failure and unexplained hepatic cirrhosis in a setting of close monitoring) and high potential for major birth defects. Liver monitoring of all patients is essential prior to initiation of treatment and monthly thereafter. Pregnancy must be excluded and prevented by two forms of birth control; monthly pregnancy tests should be obtained. Because of these risks, Tracleer is only supplied through a controlled distribution system, the Tracleer Access Program (T.A.P.(R))

About Ventavis(R)

Ventavis(R) (iloprost) is an inhaled formulation of iloprost, a synthetic compound that is structurally similar to prostacyclins -- naturally occurring molecules that cause blood vessels to dilate. Ventavis is indicated for the treatment of pulmonary arterial hypertension (WHO Group I) in patients with New York Heart Association (NYHA) Functional Class III or IV. In controlled trials, Ventavis improved a composite endpoint consisting of exercise tolerance, symptoms (NYHA Class), and lack of deterioration.

In clinical studies, common adverse reactions due to Ventavis included vasodilation (flushing), cough, headache, trismus, and insomnia. Serious adverse events reported at a rate of less than 3% included congestive heart failure, chest pain, supraventricular tachycardia, dyspnea, peripheral edema, and kidney failure. Vital signs should be monitored while initiating Ventavis. Ventavis should not be initiated in patients with systolic blood pressure less than 85 mm Hg. Stop Ventavis immediately if signs of pulmonary edema occur; this may be a sign of pulmonary venous hypertension.

About Actelion Pharmaceuticals

Actelion Pharmaceuticals has pioneered research and development in the pulmonary arterial hypertension (PAH) disease area. More than 40,000 PAH patients have been prescribed Actelion's product Tracleer, an orally available dual endothelin receptor ant
'/>"/>

SOURCE Actelion Pharmaceuticals US, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. New Survey Reveals Many Adults With High Cholesterol Fail to Take Necessary Steps to Improve Their Condition
2. International Survey Shows People Over Forty Ignore Risk of Blindness
3. 2007 Global Survey Identifies Characteristics of Supply Chain Leaders
4. Survey Sees Mass. CEOs as Bullish on Own Businesses
5. Boehringer Ingelheim Receives Top Honor as Worlds Most Respected Biopharmaceutical Employer in Science 2007 Top Employers Survey
6. Video: New Survey Finds Technology Plays a Critical Role in Lives of People with Multiple Sclerosis, Yet Many Are Not Using it to Overcome Disease-Related Challenges
7. National Survey Shows Most Women Are Not Satisfied With Their Progesterone Treatment
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... A mechanised blue dye test alternative is hel...y assurance one step closer for pharma-companies. ... machine developed by Sepha for use with bliste...al local and global pharma-companies such as Sanof...rance and productivity improvements on the packagi...
(Date:11/25/2009)..., ,, BOCA RATON, Fla., Nov. 25 /PRNewswi...l year. Not so for BodyLogicMD. The nation,s larg...ns specializing exclusively in medically supervise... physicians in its network since November 20...s to add more physician-owned centers, including o...
(Date:11/24/2009)...lable in German . , Whether it,s CD packagi...(Radio Frequency Identification) are increasingly ... possible to label objects or goods and identify t...ate scanner can read and process the data containe...ds under production conditions of up to 100 degree...
(Date:11/24/2009)... BLENHEIM, Ontario, Nov. 24 /PRNewswire-FirstCall/...acquiring the assets of Hyland Seeds, a division o...tion of Hyland Seeds will further expand Dow AgroS...icipates the introduction of SmartStax(TM) in ...it Technology in corn in 2012. The transactional c...
Breaking Biology Technology:Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4Intelligence inside metal components 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
... ChromaDex, Inc. ("ChromaDex"),today announced tha... with,CDI Acquisition, Inc. ("CDI"), the wholly-ow...TC Bulletin Board: CDYE). The transaction,enables ...ares are publicly,traded, which will help it be be...idly growing marketplace. The business and operati...
...Psychiatric Patient Evaluation for Clinical Trials...elopment, HAMILTON, N.J., July 1 MedAvante, Inc....aluation, announced today that it has,closed a $20...vi Health,Ventures. MedAvante has developed an inn...ssessment of patients undergoing treatment in clin...
... Professional Pixie Dust from Resume Writing Se... San Mateo, CA (PRWEB) July 1, 2008 -- When ...itate to use the Delete key on your professional r...n our youth-obsessed culture it can also be a hand... resume writing services and outplacement service...
Other Biology Technology:ChromaDex, Inc. Announces Completion of Reverse Merger With Cody Resources, Inc. 2MedAvante Closes $20 Million Financing by Goldman Sachs, Trevi Health Ventures 2MedAvante Closes $20 Million Financing by Goldman Sachs, Trevi Health Ventures 3MedAvante Closes $20 Million Financing by Goldman Sachs, Trevi Health Ventures 4Facelift for Resumes Offers Hope for Job Seekers, says Resume Writing Service 2Facelift for Resumes Offers Hope for Job Seekers, says Resume Writing Service 3
(Date:11/30/2009)...ealth Sciences Center New Orleans School of Public... of Child Health and Human Development (NICHD), Ha... Hospital, and Harvard Medical School, have found ...ngs of sugar- sweetened cola a week prior to pregn...developing diabetes during pregnancy. Liwei Chen, ...
(Date:11/30/2009)... scientists are presented with the complex challen... In a paper published in Insect Conservation and ...Miguel Rodriguez assess this challenge. , Twenti...30;C has already affected the Earth,s biota and no...ionary biologists is to predict how biological imp...
(Date:11/30/2009)...v. 30 Neurotechnology ( http://www...on biometric identification technologies, has rele...t line: VeriLook 4.0 Software Development Kit (S...DK for large-scale multi-biometric and automated f... capabilities in VeriLook 4.0 provide enhanced fac...
Breaking Biology News(10 mins):Sugary cola drinks linked for first time to higher risk of gestational diabetes 2Sugary cola drinks linked for first time to higher risk of gestational diabetes 3How can scientists measure evolutionary responses to climate change? 2New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 2New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 3Mettler Toledo International Inc to Host Second Quarter 2009 Earnings Conference Call 51904 1avVaa World Health Care Products Inc Announces Web Site Design for Neuroskin 28R 29 Psoriasis Relief DRTV Campaign 13064 1avVaa World Health Care Products Inc Announces Web Site Design for Neuroskin 28R 29 Psoriasis Relief DRTV Campaign 13064 2TOPICA Elects G Kirk Raab as Chairman of the Board 51901 1TOPICA Elects G Kirk Raab as Chairman of the Board 51901 2
... 31 March 2009] Researchers at the Swedish medica...ructed a mathematical activity model of the brain,...rstanding of the capacity of the working memory an...ract. One of the findings they have made with this...nal network that restricts the number of items we ...
...atment for HIV may one day help people who are not...ew research published tomorrow in The Journal of ...e simian form of HIV were able to reduce the virus...eating the monkeys with a molecule called D-1mT al...mmunodeficiency Virus (SIV) is very similar to Hum...
...Biologists is pleased to announce that its latest ...m.biologists.org) has been selected for inclusion ...e premier bibliographic database of the US Nationa...Institutes of Health (NIH), MEDLINE contains over ... on biomedicine. , DMM has been recommended f...
Other Biology News:Computer simulations explain the limitations of working memory 2Potential new HIV drug may help patients not responding to treatment 2Potential new HIV drug may help patients not responding to treatment 3Disease Models & Mechanisms -- selected for indexing in Medline 2
EDG-1 Western blot control from Exalpha Biologicals, Inc.
Stem Cell Expansion Media 1 from 3H Biomedical AB
Human TIMP-1 ELISpot Development Kit from R&D Systems
BD IMagnet 1 each from BD Biosciences Pharmingen
Biology Products: